Lineus Medical

Lineus Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.5M

Overview

Lineus Medical, founded in 2016 and headquartered in Fayetteville, Arkansas, has developed the SafeBreak Vascular device to address the high failure rate of peripheral IV lines. The device mechanically separates under tension to prevent catheter dislodgement and vein damage, with clinical data showing a 44% reduction in complications requiring IV restarts. As a private, commercial-stage company, Lineus Medical targets significant cost savings and workflow improvements for hospitals by reducing supply waste, medication spills, and nurse labor associated with frequent IV replacements.

Vascular Access

Technology Platform

Proprietary in-line breakaway device with dual-valve sealing mechanism designed to separate under harmful tension to protect IV catheters from dislodgement and prevent fluid leaks.

Funding History

1
Total raised:$1.5M
Seed$1.5M

Opportunities

The high failure rate of peripheral IVs (cited as 46%) creates a massive, addressable market across all hospitals.
The device's universal clearance for all vascular lines and pediatric use expands the total addressable market significantly.
Demonstrating clear hospital cost savings from reduced restarts, wasted supplies, and nursing labor is a powerful value proposition.

Risk Factors

Slow hospital adoption due to upfront device cost and lack of specific reimbursement codes is a primary commercial risk.
The company faces potential future competition from larger medical device firms that may introduce similar products.
As a young company, scaling manufacturing, sales, and distribution effectively presents execution risks.

Competitive Landscape

SafeBreak Vascular appears to be first-to-market as an FDA-cleared breakaway device for all vascular access lines. Traditional competition consists of standard IV securement devices (e.g., dressings, stabilizers) that do not address tensile force. Potential future competitors include other startups or divisions of large infusion therapy companies (e.g., Becton Dickinson, ICU Medical, B. Braun) that could develop similar in-line protection devices.